Position
Fidelity in Oruka Therapeutics, Inc.
Back to the book · All holders of ORKA
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $342.7M$49.05 → $95.17
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 7.26M | $220.1M | — | — | — | 0.0% |
| Q1 2026 | 7.43M | $364.5M | $49.05 | $136.1M | $8.34M | 0.0% |
| Q2 2026 | 9.06M | $862M | $95.17 | $342.7M | $154.8M | 0.0% |